10-QHealthcare

Phibro Animal Health Corporation

PAHC · Period ending 2026-09-30 · Filed 2026-11-04 · Updated

In short

Phibro Animal Health Corporation (PAHC) has revenue up 17.1% to $1.5B and net income up 106.6% to $99.7M year on year. Its net margin is 6.6% and gross margin 33.8%, and it trades at 16.2× trailing earnings. Fisclear flags 1 medium-severity risk and no high-severity ones. How we calculate this

Valuation

Healthcare
Live · Yahoo Finance

Price

$33.29

P/E (TTM)

13.3x

Price ÷ earnings per share

P/B

3.2x

Price ÷ book value

P/S (TTM)

0.9x

Price ÷ revenue per share

Beta

0.40

Low volatility vs market

PEG Ratio

1.7x

P/E ÷ earnings growth rate

52-Week Range

$28.25$33.29 now$60.08

Decision Context

The reverse DCF implies growth expectations well above historical averages. Fundamentals need to accelerate significantly to justify the current price. Consider the margin of safety before sizing a position.

Based on filing period ending Sept 2026

FisclearScore is a quantitative model using public financial data and sector median benchmarks (refreshed monthly). Not financial advice. Always conduct independent due diligence.

PAHC vs

Macro Context

Fed Funds Rate

3.88%

Accommodative

10-Year Treasury

5.13%

2026-10-01

Unemployment

4.2%

Near full employment

CPI Index

336.3

2026-09-01

M2 Money Supply

$23.4T

2026-09-01

The Federal Funds rate stands at 3.88% — a moderately elevated rate environment that raises borrowing costs across the economy; 10-year Treasury yields are at 5.13%, setting the benchmark for long-term corporate borrowing; Unemployment stands at 4.2%; Industrial production index is at 104.0; M2 money supply is $23.4T; CPI index stands at 336.3.

SWOT Analysis — PAHC

Inflationary Boom
Macro lens (Inflationary Boom): Rising costs and tighter margins amplify financial risks in this regime.
✦

Strengths

  • Net Income: $99.7M (+106.6% YoY) — Profit grew 107% — the company kept more of each dollar earned.

  • EPS (Diluted): $2.43 (+104.2% YoY) — Earnings per share rose 104% — each share earned more.

  • Gross Profit: $512.5M (+28.1% YoY) — Gross profit rose 28% — the spread between revenue and direct costs improved.

  • Revenue: $1.5B (+17.1% YoY) — Revenue grew 17% — the company sold more goods or services than the prior year.

◈

Weaknesses

  • Operating Cash Flow: $69.0M (-13.9% YoY) — Operating cash flow fell 14% but remained positive.

◎

Opportunities

No clear opportunities identified at this time.

⚠

Threats

  • Total liabilities represent 74% of total assets — elevated leverage that amplifies both gains and losses.

Year-over-Year Changes

Net Income

$99.7M

was $48.3M

+106.6%

Profit grew 107% — the company kept more of each dollar earned.

EPS (Diluted)

$2.43

was $1.19

+104.2%

Earnings per share rose 104% — each share earned more.

Gross Profit

$512.5M

was $399.9M

+28.1%

Gross profit rose 28% — the spread between revenue and direct costs improved.

Revenue

$1.5B

was $1.3B

+17.1%

Revenue grew 17% — the company sold more goods or services than the prior year.

Operating Cash Flow

$69.0M

was $80.1M

−13.9%

Operating cash flow fell 14% but remained positive.

Risk Flags

0 high · 1 medium · 0 low
  • ◈ Medium

    Total liabilities represent 74% of total assets — elevated leverage that amplifies both gains and losses.

Technical Signals

Daily closes · 1-year data

Phibro Animal Health Corporation: common questions

Is Phibro Animal Health Corporation profitable?

Yes. Phibro Animal Health Corporation made a net profit of $100M in its latest fiscal year (fiscal 2026), a net margin of 6.6%.

Is Phibro Animal Health Corporation's revenue growing?

Yes. Revenue grew 17.1% year on year, to $1.5B.

What is Phibro Animal Health Corporation's P/E ratio?

Phibro Animal Health Corporation trades at 13.3× its trailing twelve-month earnings. In other words, the share price is about 13 times the profit per share the company earned over the past year.

Does Phibro Animal Health Corporation pay a dividend?

Yes. Phibro Animal Health Corporation's forward dividend yield is 1.44%, the expected annual dividend as a share of the current share price.

What are the main risks for Phibro Animal Health Corporation?

Fisclear's checks flag 1 medium- or high-severity risk. The most serious: Total liabilities represent 74% of total assets — elevated leverage that amplifies both gains and losses.

Answers are generated from the figures in this report (updated 5 Nov 2026). Information, not investment advice.

Latest News

via Finnhub

Filing History — PAHC

Get the weekly digest

5 company reports + macro context every week, free. No spam.

  • Unlimited goal simulations
  • 5 free company report summaries per day
  • Weekly financial insights newsletter

External Links

Trade PAHC

Links open broker research pages. Not an endorsement or recommendation.

Research Phibro Animal Health Corporation

Data sourced from SEC EDGAR, FRED (Federal Reserve Economic Data), and Yahoo Finance. For informational purposes only. Not financial advice.